Sarilumab Side Effects
Medically reviewed by Drugs.com. Last updated on Sep 25, 2024.
Applies to sarilumab: subcutaneous solution.
Important warnings
This medicine can cause some serious health issues
Subcutaneous route (solution)
Risk of Serious Infections. Patients treated with sarilumab are at increased risk for developing serious infections that may lead to hospitalization or death.
Opportunistic infections have also been reported in patients receiving sarilumab.
Most patients who developed infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids.Avoid use of sarilumab in patients with an active infection.Reported infections include: Active tuberculosis, which may present with pulmonary or extrapulmonary disease.
Patients should be tested for latent tuberculosis before sarilumab use and during therapy.
Treatment for latent infection should be initiated prior to sarilumab use.
Invasive fungal infections, such as candidiasis, and pneumocystis.
Patients with invasive fungal infections may present with disseminated, rather than localized, disease.
Bacterial, viral and other infections due to opportunistic pathogens.Closely monitor patients for signs and symptoms of infection during treatment with sarilumab.
If a serious infection develops, interrupt sarilumab until the infection is controlled.Consider the risks and benefits of treatment with sarilumab prior to initiating therapy in patients with chronic or recurrent infection.
Serious side effects of sarilumab
Along with its needed effects, sarilumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking sarilumab:
More common side effects
- bloody, black, or tarry stools
- chills
- cough
- fever
- lower back or side pain
- painful or difficult urination
- pale skin
- sore throat
- ulcers, sores, or white spots in the mouth
- unusual bleeding or bruising
- unusual tiredness or weakness
Less common side effects
- bladder pain
- bloody or cloudy urine
- body ache or pain
- difficulty breathing
- ear congestion
- frequent urge to urinate
- headache
- loss of voice
- painful cold sores or blisters on the lips
- sneezing
- stuffy or runny nose
Rare side effects
- chest tightness
- difficulty swallowing
- dizziness
- fast heartbeat
- heartburn
- hives, itching, skin rash
- indigestion
- nausea
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- severe stomach pain, cramping, or burning
- vomiting of material that looks like coffee grounds, severe and continuing
Other side effects of sarilumab
Some side effects of sarilumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
For healthcare professionals
Applies to sarilumab: subcutaneous solution.
General adverse events
The most frequently reported side effects included infections, upper respiratory tract infections, urinary tract infections, nasopharyngitis, neutropenia, increased ALT, injection site erythema, leukopenia, injection site pruritus, constipation, pruritic rash, myalgia, and fatigue.
The most common side effects resulting in discontinuation were neutropenia, increased ALT, infection, COVID-19, intervertebral discitis, and pneumonia.[Ref]
Dermatologic
- Common (1% to 10%): Erythema, pruritus, pruritic rash
- Uncommon (0.1% to 1%): Cellulitis[Ref]
Gastrointestinal
- Common (1% to 10%): Oral herpes, constipation, diarrhea
- Uncommon (0.1% to 1%): Diverticulitis
- Rare (0.01% to 0.1%): Gastrointestinal (GI) perforation[Ref]
Reports of GI perforation was primarily reported as complications of diverticulitis including lower GI perforation and abscess.[Ref]
Genitourinary
- Common (1% to 10%): Urinary tract infection[Ref]
Hematologic
- Very common (10% or more): Neutropenia
- Common (1% to 10%): Leukopenia, thrombocytopenia
- Uncommon (0.1% to 1%): Decreased platelet counts[Ref]
Hepatic
- Very common (10% or more): Elevated ALT (up to 43%), elevated AST (up to 30%)
- Common (1% to 10%): Transaminases increased[Ref]
Hypersensitivity
- Uncommon (0.1% to 1%): Hypersensitivity reactions[Ref]
Immunologic
- Common (1% to 10%): Serious infections
- Frequency not reported: Immunosuppression[Ref]
Local
- Common (1% to 10%): Injection site reactions, injection site erythema, injection site pruritus[Ref]
Metabolic
- Common (1% to 10%): Lipid abnormalities, hypertriglyceridemia, hypercholesterolemia[Ref]
Lipid abnormalities included elevated low-density lipoprotein, high-density lipoprotein, and triglycerides.[Ref]
Musculoskeletal
- Common (1% to 10%): Myalgia, rheumatoid arthritis
- Frequency not reported: Intervertebral discitis
Nervous system
- Common (1% to 10%): Headache
Respiratory
- Common (1% to 10%): Upper respiratory tract infection, nasopharyngitis
- Uncommon: Pneumonia
- Frequency not reported: COVID-19, bronchitis, influenza[Ref]
Oncologic
- Common (1% to 10%): Malignancies
Other
- Common (1% to 10%): Fatigue
- Frequency not reported: Herpes zoster, drug specific antibody
References
1. (2017) "Product Information. Kevzara (sarilumab)." sanofi-aventis
2. (2023) "Product Information. Kevzara (sarilumab)." sanofi-aventis
Frequently asked questions
- What are the new drugs for rheumatoid arthritis (RA)?
- How long does it take for Kevzara to work?
- Does Kevzara cause weight gain?
- How do you use Kevzara (sarilumab) for the treatment of rheumatoid arthritis?
More about sarilumab
- Check interactions
- Compare alternatives
- Reviews (30)
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Sarilumab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.